Biodesix, Inc. Announces Inclusion of Nodify Lung® Tests in New CHEST Clinical Framework

Article summary

Biodesix, Inc. announced that the American College of Chest Physicians (CHEST) has published a new clinical framework that identifies the company's Nodify Lung® tests as a core component for lung nodule risk stratification.